Active tuberculosis in inflammatory bowel disease patients: a case–control study

Background/Aims: Anti-tumor necrosis factor (anti-TNF) drugs have been the mainstay therapy for moderate to severe inflammatory bowel disease (IBD) over the past 25 years. Nevertheless, these drugs are associated with serious opportunistic infections like tuberculosis (TB). Brazil is ranked among th...

Full description

Bibliographic Details
Main Authors: Matheus Freitas Cardoso de Azevedo, Luísa Leite Barros, Filipe Fernandes Justus, Jane Oba, Karoline Soares Garcia, Camilla de Almeida Martins, Alexandre de Sousa Carlos, André Zonetti Arruda Leite, Aytan Miranda Sipahi, Natália Sousa Freitas Queiroz, Adérson Omar Mourão Cintra Damião
Format: Article
Language:English
Published: SAGE Publishing 2023-07-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/17562848231179871